ID

25735

Descripción

Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876 Study ID: 100789 Clinical Study ID: NKV100789 Study Title: A two-part, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of single intravenous doses of GW679769 when administered alone and in combination with intravenous or oral doses of dexamethasone in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced

Palabras clave

  1. 16/9/17 16/9/17 -
Titular de derechos de autor

glaxoSmithKline

Subido en

16 de septiembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876

Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876

Regime selection
Descripción

Regime selection

Alias
UMLS CUI-1
C0013153
UMLS CUI-2
C0679006
Please select a regime for this subject and this session and press "continue".
Descripción

drug administration regime decision

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0679006
Study medication oral
Descripción

Study medication oral

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0304229
UMLS CUI-3
C1527415
Session day
Descripción

Dosing day

Tipo de datos

partialDate

Alias
UMLS CUI [1,1]
C1883016
UMLS CUI [1,2]
C0439228
Session hour
Descripción

Session hour

Tipo de datos

partialDatetime

Alias
UMLS CUI [1,1]
C1883016
UMLS CUI [1,2]
C0439227
Session minute
Descripción

Session minute

Tipo de datos

partialDatetime

Alias
UMLS CUI [1,1]
C1883016
UMLS CUI [1,2]
C0439232
Start Dose Date
Descripción

Start dose date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0178602
Start Dose Time
Descripción

Start dose time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C1301880
UMLS CUI [1,2]
C0178602
Dose amount
Descripción

Dose amount

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C1264637
Dose units
Descripción

Dose unit

Tipo de datos

text

Alias
UMLS CUI [1]
C0869039
Dose formulation
Descripción

Dose form

Tipo de datos

text

Alias
UMLS CUI [1]
C0013058
Dose route
Descripción

Dose route

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0679006
Study Medication IV
Descripción

Study Medication IV

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0304229
UMLS CUI-3
C1522726
Session day
Descripción

Dosing day

Tipo de datos

partialDate

Alias
UMLS CUI [1,1]
C1883016
UMLS CUI [1,2]
C0439228
Session hour
Descripción

Session hour

Tipo de datos

partialDatetime

Alias
UMLS CUI [1,1]
C1883016
UMLS CUI [1,2]
C0439227
Session minute
Descripción

Session minute

Tipo de datos

partialDatetime

Alias
UMLS CUI [1,1]
C1883016
UMLS CUI [1,2]
C0439232
Start Dose Date
Descripción

Start dose date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0178602
Start Dose Time
Descripción

Start dose time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C1301880
UMLS CUI [1,2]
C0178602
End Dose Date
Descripción

End Dose Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C0178602
End Dose Time
Descripción

End Dose Time

Tipo de datos

time

Alias
UMLS CUI [1,1]
C1522314
UMLS CUI [1,2]
C0178602
Start Dose Volume
Descripción

Start Dose Volume

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0449468
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0439659
End Dose Volume
Descripción

End Dose Volume

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0449468
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0444930
Dose amount
Descripción

Dose amount

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C1264637
Dose units
Descripción

Dose unit

Tipo de datos

text

Alias
UMLS CUI [1]
C0869039
Dose formulation
Descripción

Dose form

Tipo de datos

text

Alias
UMLS CUI [1]
C0013058
Dose route
Descripción

Dose route

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C0679006

Similar models

Dosing regime - GSK Study: GW679769 administered alone vs. with dexamethasone - Evaluation of safety, tolerability and pharmacokinetics NCT00291876

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Regime selection
C0013153 (UMLS CUI-1)
C0679006 (UMLS CUI-2)
Item
Please select a regime for this subject and this session and press "continue".
integer
C0013153 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
Code List
Please select a regime for this subject and this session and press "continue".
CL Item
O-Single 150mg Oral of GW679769 (1)
CL Item
P-Placebo for IV GW679769 (2)
CL Item
X1-IV GW679769 12mg (3)
CL Item
X2-IV GW679769 12-35mg (4)
CL Item
X3-IV GW679769 35-70mg (5)
CL Item
X4-IV GW679769 70-130mg (6)
Item Group
Study medication oral
C0013227 (UMLS CUI-1)
C0304229 (UMLS CUI-2)
C1527415 (UMLS CUI-3)
Dosing day
Item
Session day
partialDate
C1883016 (UMLS CUI [1,1])
C0439228 (UMLS CUI [1,2])
Session hour
Item
Session hour
partialDatetime
C1883016 (UMLS CUI [1,1])
C0439227 (UMLS CUI [1,2])
Session minute
Item
Session minute
partialDatetime
C1883016 (UMLS CUI [1,1])
C0439232 (UMLS CUI [1,2])
Start dose date
Item
Start Dose Date
date
C0808070 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Start dose time
Item
Start Dose Time
time
C1301880 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dose amount
Item
Dose amount
integer
C0178602 (UMLS CUI [1,1])
C1264637 (UMLS CUI [1,2])
Dose unit
Item
Dose units
text
C0869039 (UMLS CUI [1])
Dose form
Item
Dose formulation
text
C0013058 (UMLS CUI [1])
Dose route
Item
Dose route
text
C0013153 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
Item Group
Study Medication IV
C0013227 (UMLS CUI-1)
C0304229 (UMLS CUI-2)
C1522726 (UMLS CUI-3)
Dosing day
Item
Session day
partialDate
C1883016 (UMLS CUI [1,1])
C0439228 (UMLS CUI [1,2])
Session hour
Item
Session hour
partialDatetime
C1883016 (UMLS CUI [1,1])
C0439227 (UMLS CUI [1,2])
Session minute
Item
Session minute
partialDatetime
C1883016 (UMLS CUI [1,1])
C0439232 (UMLS CUI [1,2])
Start dose date
Item
Start Dose Date
date
C0808070 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Start dose time
Item
Start Dose Time
time
C1301880 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
End Dose Date
Item
End Dose Date
date
C0806020 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
End Dose Time
Item
End Dose Time
time
C1522314 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Start Dose Volume
Item
Start Dose Volume
text
C0449468 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0439659 (UMLS CUI [1,3])
End Dose Volume
Item
End Dose Volume
text
C0449468 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0444930 (UMLS CUI [1,3])
Dose amount
Item
Dose amount
integer
C0178602 (UMLS CUI [1,1])
C1264637 (UMLS CUI [1,2])
Dose unit
Item
Dose units
text
C0869039 (UMLS CUI [1])
Dose form
Item
Dose formulation
text
C0013058 (UMLS CUI [1])
Dose route
Item
Dose route
text
C0013153 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial